Purple Biotech (PPBT) Receivables - Other (2014 - 2024)

Purple Biotech (PPBT) reported Receivables - Other of $1000.0 for Q4 2024, little changed year-over-year from $1000.0 in Q1 2024, and little changed on a QoQ basis from $1000.0 in Q4 2023.

Purple Biotech (PPBT) has 5 years of Receivables - Other data on file, last reported at $1000.0 in Q4 2024.

  • Quarterly Receivables - Other changed 0.0% year-over-year to $1000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $1000.0 (changed 0.0% YoY) and the FY2024 annual result came in at $1000.0, changed 0.0% from the prior year.
  • Receivables - Other was little changed at $1000.0 in Q4 2024 per PPBT's latest filing, from $1000.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $6000.0 in Q4 2021 and bottomed at $1000.0 in Q4 2023.
  • The 3-year median for Receivables - Other is $1000.0 (2023), against an average of $2666.7.
  • Peak annual rise in Receivables - Other reached 0.0% in 2024, while the deepest fall reached 0.0% in 2024.
  • Tracing PPBT's Receivables - Other over 3 years: stood at $6000.0 in 2021, then sank by 83.33% to $1000.0 in 2023, then changed by 0.0% to $1000.0 in 2024.
  • Per Business Quant, the three latest PPBT Receivables - Other figures stand at $1000.0 (Q4 2024), $1000.0 (Q4 2023), and $6000.0 (Q4 2021).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Purple Biotech 3.58 Bn 3.57 Bn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 1,000.00
Dec 31, 2024 1,000.00
Dec 31, 2023 1,000.00
Dec 31, 2023 1,000.00
Dec 31, 2021 6,000.00
Dec 31, 2021 6,000.00
Dec 31, 2017 590,000.00
Dec 31, 2017 590,000.00
Jun 30, 2017 762,000.00
Jun 30, 2017 762,000.00
Dec 31, 2016 241,000.00
Dec 31, 2016 241,000.00
Jun 30, 2016 644,000.00
Jun 30, 2016 644,000.00
Dec 31, 2015 246,000.00
Dec 31, 2015 246,000.00
Sep 30, 2015 553,000.00
Sep 30, 2015 553,000.00
Dec 31, 2014 446,000.00
Dec 31, 2014 446,000.00
Sep 30, 2014 445,000.00
Sep 30, 2014 445,000.00